IN2012DN02245A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02245A IN2012DN02245A IN2245DEN2012A IN2012DN02245A IN 2012DN02245 A IN2012DN02245 A IN 2012DN02245A IN 2245DEN2012 A IN2245DEN2012 A IN 2245DEN2012A IN 2012DN02245 A IN2012DN02245 A IN 2012DN02245A
- Authority
- IN
- India
- Prior art keywords
- nutritional compositions
- vitamin
- nutritional
- osteopontin
- manganese
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 4
- 235000016709 nutrition Nutrition 0.000 abstract 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- 102000004264 Osteopontin Human genes 0.000 abstract 1
- 108010081689 Osteopontin Proteins 0.000 abstract 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 abstract 1
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 abstract 1
- 239000011574 phosphorus Substances 0.000 abstract 1
- 229910052698 phosphorus Inorganic materials 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 235000019143 vitamin K2 Nutrition 0.000 abstract 1
- 239000011728 vitamin K2 Substances 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pediatric Medicine (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
Abstract
Nutritional compositions and methods of making and using the nutritional compositions are provided. In a general embodiment, the present disclosure provides a nutritional composition including exogenous vitamin K2. The nutritional compositions may further include an additional component selected from the group consisting of phosphorus, magnesium, zinc, iron, copper, manganese, calcium, vitamin D, osteopontin and combinations thereof.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24208709P | 2009-09-14 | 2009-09-14 | |
| US25084709P | 2009-10-12 | 2009-10-12 | |
| US34794510P | 2010-05-25 | 2010-05-25 | |
| US37184610P | 2010-08-09 | 2010-08-09 | |
| PCT/US2010/047468 WO2011031602A1 (en) | 2009-09-14 | 2010-09-01 | Nutritional compositions for modulating inflammation including exogenous vitamin k2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02245A true IN2012DN02245A (en) | 2015-05-22 |
Family
ID=43098924
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2245DEN2012 IN2012DN02245A (en) | 2009-09-14 | 2010-09-01 | |
| IN2184DEN2012 IN2012DN02184A (en) | 2009-09-14 | 2010-09-01 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2184DEN2012 IN2012DN02184A (en) | 2009-09-14 | 2010-09-01 |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US20130052274A1 (en) |
| EP (2) | EP2477510B1 (en) |
| JP (3) | JP2013504571A (en) |
| CN (2) | CN102781258A (en) |
| AU (2) | AU2010292440B2 (en) |
| BR (1) | BR112012005783A2 (en) |
| CA (2) | CA2773940A1 (en) |
| DK (1) | DK2477510T3 (en) |
| ES (1) | ES2669004T3 (en) |
| IN (2) | IN2012DN02245A (en) |
| MX (2) | MX2012003080A (en) |
| PH (2) | PH12012500488A1 (en) |
| RU (2) | RU2012114832A (en) |
| SG (2) | SG179065A1 (en) |
| TR (1) | TR201808128T4 (en) |
| WO (2) | WO2011031602A1 (en) |
| ZA (2) | ZA201202711B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130028864A1 (en) * | 1998-04-08 | 2013-01-31 | Theta Biomedical Consulting & Development Co., Inc. | Anti-inflammatory compositions for treating brain inflammation |
| CA2773940A1 (en) * | 2009-09-14 | 2011-03-17 | Nestec S.A. | Nutritional compositions including exogenous vitamin k2 |
| PH12013501926A1 (en) * | 2011-04-18 | 2013-10-14 | Nestec Sa | Nutritional compositions having alpha-hica and citrulline |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
| CN102772401A (en) * | 2011-10-02 | 2012-11-14 | 南京大学 | Novel osteoporosis resistant use of carnosol |
| WO2013144268A1 (en) * | 2012-03-29 | 2013-10-03 | Nestec S.A. | Nutrition and exercise against drug-associated malnutrition in children |
| WO2013144267A2 (en) * | 2012-03-29 | 2013-10-03 | Nestec S.A. | Improvement of musculoskeletal health by nutrition and exercise |
| AU2013298645B2 (en) | 2012-07-31 | 2016-11-03 | Société des Produits Nestlé S.A. | Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (IBD) |
| US20150250839A1 (en) * | 2012-09-11 | 2015-09-10 | Dakota Star Capital Llc | Nutritional supplement containing iron |
| CN103142640A (en) * | 2013-04-01 | 2013-06-12 | 李拖平 | Health care product containing vitamin K2 and having functions of preventing and treating brittle-bone disease |
| WO2017114686A1 (en) * | 2015-12-30 | 2017-07-06 | Nestec S.A. | Method for determining fat free body mass |
| CN105815791B (en) * | 2016-03-24 | 2018-12-18 | 刘超 | It is a kind of with muscle-increasing function and to eliminate the composition of adverse reaction |
| US20200315233A1 (en) * | 2016-06-02 | 2020-10-08 | Ana Pharmaceuticals, Inc. | Methods and compositions for treatment of hypercalciuria and nephrolithiasis |
| US20220175851A1 (en) * | 2019-03-13 | 2022-06-09 | The Regents Of The University California | Compositions, methods for regulating uterine, placental growth |
| CN110122866A (en) * | 2019-05-31 | 2019-08-16 | 广东双骏生物科技有限公司 | A kind of the special medicine purposes food and preparation method of chronic kidney disease angiosteosis |
| TR202002698A2 (en) * | 2020-02-21 | 2021-09-21 | Montero Gida Sanayi Ve Ticaret Anonim Sirketi | Nutritional compositions for cancer patients undergoing chemotherapy and/or radiotherapy and/or pre-post surgery |
| WO2023275183A1 (en) | 2021-06-29 | 2023-01-05 | Kappa Bioscience As | Composition comprising vitamin k, vitamin d, xanthophyll and epa and/or dha |
| CN115989871A (en) * | 2021-10-20 | 2023-04-21 | 安琪纽特股份有限公司 | A growth-promoting composition and its preparation method and application |
| CN115590198B (en) * | 2022-09-26 | 2024-06-18 | 黑龙江飞鹤乳业有限公司 | Use of nucleotide, nutritional composition, food and use thereof |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US250847A (en) | 1881-12-13 | Vehicle-top | ||
| US242087A (en) | 1881-05-24 | Machine for making laps on belting | ||
| US347945A (en) | 1886-08-24 | vavtu | ||
| US371846A (en) | 1887-10-18 | Tennis-racket | ||
| JPH07119191B2 (en) * | 1990-08-16 | 1995-12-20 | 株式会社日本触媒 | Method for stabilizing menadione bisulfite and composition of menadione bisulfite |
| US5132113A (en) * | 1990-10-26 | 1992-07-21 | Maurizio Luca | Nutritional composition containing essential amino acids |
| EP0689835A3 (en) * | 1994-06-30 | 1996-04-17 | Ajinomoto Kk | Composition comprising a mixture of amino acids and at least one N-3 fatty acid |
| AU2804297A (en) * | 1996-04-22 | 1997-11-12 | Advanced Polymer Systems Inc. | Method of and composition for treating disorders of the skin using vitamin k |
| JP3459932B2 (en) * | 1996-07-23 | 2003-10-27 | 株式会社ホーネンコーポレーション | Anti-osteoporosis composition |
| DE60036750T2 (en) * | 1999-05-18 | 2008-08-28 | Nipro Corp. | Method for estimating the sensitivity to osteoporosis drugs |
| ES2286070T3 (en) * | 2000-05-12 | 2007-12-01 | Nattopharma Asa | FOOD PRODUCT CONTAINING VITAMIN K2. |
| NZ507335A (en) * | 2000-10-05 | 2004-10-29 | New Zealand Dairy Board | Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP |
| GB2370503A (en) * | 2000-12-27 | 2002-07-03 | Novartis Nutrition Ag | Compositions comprising vitamin K |
| JP4131443B2 (en) * | 2001-08-27 | 2008-08-13 | 株式会社Ｊ−オイルミルズ | Anti-osteoporosis composition |
| JP2004155658A (en) * | 2002-11-01 | 2004-06-03 | Kyowa Hakko Kogyo Co Ltd | TNF-α production inhibitor |
| WO2005030190A1 (en) * | 2003-09-26 | 2005-04-07 | Natural Asa | Natural menaquinone 7 compositions |
| WO2005107731A1 (en) * | 2004-05-12 | 2005-11-17 | Eisai R & D Management Co., Ltd. | Remedies containing vitamin k2 as the active ingredient |
| EP1781116A4 (en) * | 2004-06-04 | 2009-07-29 | Horizon Science Pty Ltd | NATURAL SWEETENER |
| US20060223730A1 (en) * | 2005-04-04 | 2006-10-05 | Hl Distribution Company | Calcium supplements |
| JP2006325487A (en) * | 2005-05-26 | 2006-12-07 | Pola Chem Ind Inc | Nutrient-supplementary solid food |
| WO2006126541A1 (en) * | 2005-05-27 | 2006-11-30 | Shionogi & Co., Ltd. | Pharmaceutical composition comprising vitamin k |
| BE1016895A6 (en) * | 2005-12-16 | 2007-09-04 | Psaltopoulos Emmanuel | Calcium composition, useful to prevent/treat osteoporosis and articular cartilage calcification, comprises optionally elementary calcium in the form e.g. of calcium carbonate or calcium citrate, and vitamins e.g. vitamin-D3, vitamin-K3 |
| US20080171319A1 (en) * | 2006-02-06 | 2008-07-17 | Mickey Urdea | Osteoporosis associated markers and methods of use thereof |
| US9011930B2 (en) * | 2006-05-01 | 2015-04-21 | Zycal Bioceuticals Healthcare Company, Inc. | Nutritional supplement and use thereof |
| EP2046312B1 (en) * | 2006-07-14 | 2020-02-19 | Kaydence Pharma AS | Pharmaceutical and nutraceutical products comprising vitamin k2 |
| FR2906816B1 (en) * | 2006-10-04 | 2012-04-06 | Gervais Danone Sa | VARIANTS OF LACTIC ACID BACTERIA USEFUL IN PRODUCING VITAMIN K2 AND THEIR APPLICATIONS TO THE PREPARATION OF FOOD PRODUCTS |
| US20080220094A1 (en) * | 2006-11-01 | 2008-09-11 | Wyeth | Compositions and methods for the treatment and/or prevention of osteoporosis |
| MX2010000927A (en) * | 2007-07-24 | 2010-05-19 | Viridis Biopharma Pvt Ltd | Treatment of human disease conditions and disorders using vitamin k analogues and derivatives. |
| NL1034964C2 (en) * | 2008-01-28 | 2009-07-30 | Friesland Brands Bv | Method and compositions for the treatment of bone disorders. |
| WO2009105234A2 (en) * | 2008-02-19 | 2009-08-27 | Combinatorx, Incorporated | Methods and compositions for the treatment of disorders associated with defects of the cystic fibrosis transmembrane conductance regulator gene or protein |
| US8815953B2 (en) * | 2008-03-13 | 2014-08-26 | Spectrum Pharmaceuticals, Inc. | Formulations of vitamin K analogs for topical use |
| CA2773940A1 (en) * | 2009-09-14 | 2011-03-17 | Nestec S.A. | Nutritional compositions including exogenous vitamin k2 |
-
2010
- 2010-09-01 CA CA2773940A patent/CA2773940A1/en not_active Abandoned
- 2010-09-01 IN IN2245DEN2012 patent/IN2012DN02245A/en unknown
- 2010-09-01 SG SG2012016622A patent/SG179065A1/en unknown
- 2010-09-01 PH PH1/2012/500488A patent/PH12012500488A1/en unknown
- 2010-09-01 TR TR2018/08128T patent/TR201808128T4/en unknown
- 2010-09-01 ES ES10752497.7T patent/ES2669004T3/en active Active
- 2010-09-01 IN IN2184DEN2012 patent/IN2012DN02184A/en unknown
- 2010-09-01 RU RU2012114832/13A patent/RU2012114832A/en not_active Application Discontinuation
- 2010-09-01 WO PCT/US2010/047468 patent/WO2011031602A1/en active Application Filing
- 2010-09-01 EP EP10752497.7A patent/EP2477510B1/en active Active
- 2010-09-01 US US13/395,054 patent/US20130052274A1/en not_active Abandoned
- 2010-09-01 RU RU2012114786/15A patent/RU2012114786A/en not_active Application Discontinuation
- 2010-09-01 US US13/395,060 patent/US20120208893A1/en not_active Abandoned
- 2010-09-01 CN CN2010800504018A patent/CN102781258A/en active Pending
- 2010-09-01 DK DK10752497.7T patent/DK2477510T3/en active
- 2010-09-01 CN CN2010800508998A patent/CN102596190A/en active Pending
- 2010-09-01 SG SG2012016614A patent/SG179064A1/en unknown
- 2010-09-01 PH PH1/2012/500489A patent/PH12012500489A1/en unknown
- 2010-09-01 MX MX2012003080A patent/MX2012003080A/en unknown
- 2010-09-01 WO PCT/US2010/047465 patent/WO2011031601A2/en active Application Filing
- 2010-09-01 AU AU2010292440A patent/AU2010292440B2/en active Active
- 2010-09-01 JP JP2012528830A patent/JP2013504571A/en active Pending
- 2010-09-01 CA CA2773957A patent/CA2773957C/en active Active
- 2010-09-01 BR BR112012005783A patent/BR112012005783A2/en not_active IP Right Cessation
- 2010-09-01 MX MX2012003081A patent/MX2012003081A/en not_active Application Discontinuation
- 2010-09-01 JP JP2012528831A patent/JP2013504572A/en active Pending
- 2010-09-01 AU AU2010292439A patent/AU2010292439A1/en not_active Abandoned
- 2010-09-01 EP EP10752687A patent/EP2477618A2/en not_active Withdrawn
-
2012
- 2012-04-13 ZA ZA2012/02711A patent/ZA201202711B/en unknown
- 2012-04-13 ZA ZA2012/02712A patent/ZA201202712B/en unknown
-
2013
- 2013-08-09 US US13/963,244 patent/US20130323361A1/en not_active Abandoned
-
2015
- 2015-10-02 JP JP2015196933A patent/JP2016041705A/en active Pending
-
2016
- 2016-04-14 US US15/099,257 patent/US9687456B2/en active Active
- 2016-12-23 US US15/389,945 patent/US20170105948A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02184A (en) | ||
| EP4553149A3 (en) | Liver organoid, uses thereof and culture method for obtaining them | |
| WO2009076676A3 (en) | Compositions and methods for producing isoprene | |
| EP3124624A3 (en) | Methylation markers for lung cancer | |
| PH12014500271A1 (en) | Solder compositions | |
| ZA201102754B (en) | Lipochito-oligosaccharides stimulating arbuscular mycorrhizal symbiosis | |
| EP2322139A3 (en) | Composition comprising a polyol and an oil-soluble high carbon polar modified polymer | |
| EP2322248A3 (en) | Composition comprising a polyol and an oil-soluble polar modified polymer | |
| EP2245113A4 (en) | Phosphorescent compositions, methods of making the compositions, and methods of using the compositions | |
| EP2316413A3 (en) | Compositions comprising an nfkb-inhibitor and a non-retinoid collagen promoter | |
| MX348325B (en) | Galacto-oligosaccharide-containing composition and a method of producing it. | |
| WO2011023560A3 (en) | Deodorizing compositions | |
| WO2011019641A3 (en) | Nutritional compositions including exogenous nucleotides | |
| WO2012036329A1 (en) | Composition or kit for making a prognosis of liver cancer, and method for making a prognosis of liver cancer | |
| IL212713A0 (en) | Kits and compositions comprising methotrexate combinations and uses thereof. | |
| MX2011013790A (en) | Flavin derivatives. | |
| GB201001779D0 (en) | Composition | |
| ZA201309363B (en) | Air hardenable shock-resistant steel alloys,method of making the alloys,and articles including the alloys. | |
| AU321758S (en) | Images and sound editor | |
| GB2495687A (en) | Nutritional compositions comprising chitin microparticles | |
| WO2012033893A3 (en) | Hyperhalogens and highly electronegative compositions | |
| WO2012064557A3 (en) | Deodorizing compositions | |
| TW200616629A (en) | Phenanthridine carbonyl phenols | |
| MX2015001982A (en) | Process for production of rosin resin, product obtained by said process and use thereof. | |
| WO2010129789A3 (en) | Modified tumor necrosis factor-beta |